Four characters naming one of the most studied human antimicrobial peptides.
Short, alphanumeric, and instantly legible to anyone in peptide science, LL37 reads as a compound designation rather than a marketing coinage. It types in a keystroke, survives being spoken aloud on a call, and fits a logo without compression. Names this brief in .com rarely correspond to a live research vocabulary term, which is what gives this one its unusual dual value.
Ideal for a research supplier stocking antimicrobial and wound-healing peptides, a dermatology venture working on barrier and innate immunity, or a laboratory publishing technical documentation to a scientific readership. A descriptive multi-word alternative would sprawl across three hyphens and still lose recall; this one is remembered the first time it is seen.
Well suited to
Ideal owner A peptide research company or innate-immunity biotech.
Acquire LL37.com outright, structure a strategic lease, or arrange lease-to-own — qualified inquiries only. Transactions are handled discreetly and can be escrow-secured.
